Effect of entecavir therapy on chronic hepatitis B patients for 48 weeks

Clinical Focus ›› 2015, Vol. 30 ›› Issue (8): 899-902.

Previous Articles Next Articles

Effect of entecavir therapy on chronic hepatitis B patients for 48 weeks

Wang Guixia;Zeng Yue;Meng Huanghua

Online:2015-08-05 Published:2015-08-05

Abstract

CLC Number:

R514

Wang Guixia;Zeng Yue;Meng Huanghua. Effect of entecavir therapy on chronic hepatitis B patients for 48 weeks[J]. Clinical Focus, 2015, 30(8): 899-902.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2015/V30/I8/899

[1]	Ma Jincai, Ma Rongzhi, Ma Zhenzhen. Efficacy and safety of rivaroxaban in elderly patients with nonvalvular atrial fibrillation complicated with cardiac insufficiency [J]. Clinical Focus, 2020, 35(5): 413-416.
[2]	Li Changqing1,2， Chai Erqing2， Jiang Lei1. Efficacy and safety of tirofiban in mechanical thrombectomy for acute ischemic stroke [J]. Clinical Focus, 2018, 33(9): 787-791,795.
[3]	Liu Likun, Liang Juyou, Chen Jing, Yao Yao, Guo Meng, Li Xiaona, Zhao Junli, Zhao Yiran, Xing Qiaoling, Pan Hongjuan, Li Xutong. Study on the identification of a case with blood type B(A) and the concerned clinical safety transfusion strategies [J]. Clinical Focus, 2018, 33(6): 510-514.
[4]	Jing Hongfei， Wang Yanfang， Wang Long. Safety and efficacy of urokinase plus tirofiban in treatment of acute ischemic stroke patients [J]. Clinical Focus, 2018, 33(5): 409-412.
[5]	LIU Ya;WU Jin-ming;CHEN Mei-qin. Efficacy of entecavir for 96 weeks in patients with hepatitis B virus-related cirrhosis and chronic hepatitis B [J]. Clinical Focus, 2014, 29(6): 672-675.
[6]	YAN Na-xin;HUO Jian-feng;LU Fei;DU Jing;LI Tie-niu;ZHAO Zhao-xia;DAI Er-hei. Analysis on L-nucleoside antiviral drug resistance mutation in Shijiazhuang region [J]. Clinical Focus, 2014, 29(10): 1175-1177.

Effect of entecavir therapy on chronic hepatitis B patients for 48 weeks

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 6

Recommended Articles

Metrics

Comments